Patent · US Active

Platform for generating safe cell therapeutics

US10927349B2 · kind B2 · utility

4Cited by
5References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 16, 2019
Grant dateFeb 23, 2021
Priority date—
Expiry dateDec 16, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2513/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are cytoplasts (enucleated cells), methods for making cytoplasts, compositions comprising cytoplasts, and methods for using cytoplasts.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.